SUBSCRIBE
SUBSCRIBE

Janssen Pharmaceutical Inc.

NEWS
BioForest
Clinical Catch-Up: September 14-18
It was a fairly busy week for clinical trial announcements, with some important and interesting news about COVID-19 treatments and vaccines, as well as numerous stories about non-COVID-19 studies.
September 18, 2020
 · 
11 min read
 · 
Mark Terry
Drug Development
Biopharma Update on the Novel Coronavirus: September 4
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 4, 2020.
September 3, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Courtesy of Michael Vi/Getty Images
Pharm Country
J&J Abandons Influenza A Treatment Program After Interim Analysis
Janssen Pharmaceutical of Johnson & Johnson made a strategic call to halt development of pimodivir, an antiviral treatment for influenza A.
September 2, 2020
 · 
3 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: August 12
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
August 11, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: August 5
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 5, 2020.
August 4, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Clinical Catch-Up: July 13-17
It was a surprisingly big week for clinical trial updates related to COVID-19, although there was plenty of non-COVID-19 news as well. Here’s a look.
July 17, 2020
 · 
8 min read
 · 
Mark Terry
FDA
Janssen’s Tremfya Snags Approval as First IL-23 Treatment for Active Psoriatic Arthritis
In announcing the approval this morning, Janssen said IL-23 is a naturally occurring cytokine involved in normal inflammatory and immune responses associated with symptoms of psoriatic arthritis.
July 14, 2020
 · 
2 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: July 6
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 6, 2020.
July 6, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Business
Emergent and J&J Ink 5-Year COVID-19 Vaccine Manufacturing Deal
Emergent will handle contract development and manufacturing (CDMO) services in a deal that is valued at about $480 million for the first two years.
July 6, 2020
 · 
3 min read
 · 
Mark Terry
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Updated Amivantamab and Lazertinib Combination Data Demonstrate Durable Responses and Clinical Activity for Osimertinib-Relapsed Patients with EGFR-Mutated Non-Small Cell Lung Cancer
May 19, 2021
 · 
15 min read
Pharm Country
IMBRUVICA® (ibrutinib)-Based Combination Regimen as a Fixed-Duration, First-Line Treatment for Chronic Lymphocytic Leukemia Demonstrates High Rates of Disease Control
May 19, 2021
 · 
17 min read
Pharm Country
Late-Breaking Data at ACC.21 Show XARELTO® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization
May 16, 2021
 · 
16 min read
Drug Development
New Phase 3 Data Showed First-in-Class TREMFYA® (guselkumab) Provided Durable Complete Skin Clearance Through Five Years in Moderate to Severe Plaque Psoriasis (PsO)
April 23, 2021
 · 
21 min read
Business
PhysIQ Announces Strategic Collaboration to Scale Digital Medicine
April 20, 2021
 · 
3 min read
Biotech Bay
New Real-World Observational Analysis of UPTRAVI® (selexipag) Underscores the Importance of Risk Assessment for Treating Pulmonary Arterial Hypertension (PAH) Patients
April 6, 2021
 · 
12 min read
Business
Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza
April 5, 2021
 · 
6 min read
Drug Development
New Phase 3 Data Show First-in-Class TREMFYA® (guselkumab) Achieved Complete Skin Clearance and Favorable Joint Efficacy in Adult Patients with Active Psoriatic Arthritis (PsA) Through Two Years
March 16, 2021
 · 
22 min read
Policy
Health Canada authorizes Janssen COVID-19 vaccine
March 5, 2021
 · 
1 min read
Lone Star Bio
Beyond Batten Disease Foundation Announces Agreement with Actelion Pharmaceuticals Ltd to Provide Drug Product for BBDF-101
March 2, 2021
 · 
4 min read
Load More